CASI Pharmaceuticals, Inc. Gains 21.76%
Fri, Oct 30, 2020 at 05:30 PM
CASI Pharmaceuticals, Inc. (CASI:NASDAQ) rocketted at $2.35, a gain of 21.8%. The stock appeared on our News Catalysts scanner on Tue 27 Oct 20 at 10:22 AM in the 'MISCELLANEOUS' category. From Thu 15 Oct 20, the stock recorded 30.00% Up Days and 18.18% Green Days
About CASI Pharmaceuticals, Inc. (CASI:NASDAQ)
CASI Pharmaceuticals Inc is engaged in research and development of biopharmaceutical products. It mainly focuses on acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs.
Top 10 Gainers:
- BioLineRx Ltd. (BLRX:NASDAQ), 33.78%
- Tricida, Inc. (TCDA:NASDAQ), 28.83%
- Air Industries Group (AIRI:NYSEMKT), 27.82%
- Daseke, Inc. (DSKE:NASDAQ), 26.59%
- Build-A-Bear Workshop, Inc. (BBW:NYSE), 24.4%
- Acadia Healthcare Company, Inc. (ACHC:NASDAQ), 23.02%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 22.22%
- MICT, Inc. (MICT:NASDAQ), 21.88%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 21.76%
- LNSR (LNSR:NASDAQ), 19.61%